Skip to content

APOTHEEK JANSSEN

Active
Public limited companyfounded 1983active for 42 yearsVelostraat 48, 9800 Deinze, BelgiumKBO/BCE: BE 0425.202.369
Summary

APOTHEEK JANSSEN has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €68,200 and a net result of €67,165. Equity is shrinking by about 35% per year across the filed financial years. Its solvency ranks better than 21% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
APOTHEEK JANSSENActiveChecked score 92/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€655,639total assets 2025
Staff
1.3 FTE
Equity
€68,200
Profit
€67,165
Turnover not published (abbreviated format)
Financial health
92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
Parent
ARCOFAR · 99.96%
  • ARCOFARDirector · permanent representative NOË Geert Adrien MarieThérèse
  • DE CONINCK LeenDirector
Accounts 49 days early1 of 5 deeds read
Why 92raises riskEquity €68,200 (10.4% of total assets)Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 4.63, cash €388,751Founded in 1983Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 55% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 35-3
equity 10.4% of total assets
Liquidity 93+41
short-term debt 21.5% · cash 59.3%
Profitability 82=
return on assets 10.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,222 companies, NACE 47, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025lowest value 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026highest value 07-2026: 0.1%▼ -0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €6,000 on 30-day terms is acceptable
Liquidity ample (current ratio 4.63, compared with 1.14 in 2024, above the usual 1.5; short-term debt: 21.5% and cash: 59.3% of total assets), but 89.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 27% on solvency, 93% on liquidity, 74% on profitability and 28% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €68,200 (10.4% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 4.63, cash €388,751
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Founded in 1983
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 21% of 12661 sector peers (2025).
NBB · sector comparison
Position among 12661 sector peers
Solvency
better than 21%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-06-2026, 49 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
49 days early
2024
38 days early
2023
8 days early
2022
62 days early
2021
46 days early
2020
22 days early
2019
46 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 39 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 15 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €67,165 ▲13.9%
  3. Liquidity quadruplescurrent ratio 4.63

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €67,165 8 years View
  • Controlled by ARCOFAR 99.96% View

By topic

Financials

Financial year
2025
Total assets
€655,639
Profit
€67,165
Solvency
10.4%
Total assets▲ 14.9%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
ARCOFAR · 99.96%
  • ARCOFARDirector
  • DE CONINCK LeenDirector
Go to Board & ownership

Timeline

Events
46
Since
1985
Next accounts
by 31-07-2027
  1. 23-06-2025Annual accounts filed
  2. 23-07-2024Annual accounts filed
  3. 22-09-2023Resignations: DE CONINCK Leen (director) and ARCOFAR…
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
31-12-1983
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
32
Annual meeting
15 June at 10:00
Purpose
“De kleinhandel in farmaceutische producten en geneeskundige planten en kruiden; De…” (deed in Dutch)
Go to Articles of association

Key facts about APOTHEEK JANSSEN

What is the company number of APOTHEEK JANSSEN?
0425.202.369. In Belgium the VAT number is the company number with BE in front: BE 0425.202.369.
Where is APOTHEEK JANSSEN based?
The registered office is at Velostraat 48, 9800 Deinze.Company details
What does APOTHEEK JANSSEN do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK JANSSEN?
Public limited company (NV).
When was APOTHEEK JANSSEN founded?
On 31-12-1983.
Is APOTHEEK JANSSEN still active?
Yes, APOTHEEK JANSSEN is an active enterprise in the KBO register.
How many employees does APOTHEEK JANSSEN have?
On average 1.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of APOTHEEK JANSSEN?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is APOTHEEK JANSSEN profitable?
In financial year 2025, APOTHEEK JANSSEN made a profit of €67,165.
Where can I find the annual accounts of APOTHEEK JANSSEN?
APOTHEEK JANSSEN filed 42 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK JANSSEN due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to APOTHEEK JANSSEN

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure